ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $29,000 | -92.1% | 17,197 | -91.0% | 0.00% | -94.1% |
| Q3 2015 | $365,000 | +189.7% | 191,236 | +606.0% | 0.02% | +240.0% |
| Q2 2015 | $126,000 | -75.2% | 27,087 | -81.5% | 0.01% | -70.6% |
| Q4 2014 | $509,000 | +569.7% | 146,694 | +708.9% | 0.02% | +750.0% |
| Q3 2014 | $76,000 | -83.9% | 18,134 | -77.5% | 0.00% | -84.6% |
| Q2 2014 | $471,000 | +153.2% | 80,435 | +172.2% | 0.01% | +160.0% |
| Q1 2014 | $186,000 | -48.3% | 29,551 | -52.0% | 0.01% | -54.5% |
| Q4 2013 | $360,000 | -49.7% | 61,602 | -54.6% | 0.01% | -47.6% |
| Q3 2013 | $716,000 | +181.9% | 135,791 | +312.2% | 0.02% | +162.5% |
| Q2 2013 | $254,000 | – | 32,939 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 7,500,000 | $34,800,000 | 2.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,983,710 | $32,404,000 | 1.08% |
| DAFNA Capital Management LLC | 189,000 | $877,000 | 0.74% |
| Lyons Wealth Management, LLC. | 56,665 | $264,000 | 0.30% |
| Telemetry Investments, L.L.C. | 110,000 | $510,000 | 0.23% |
| Callan Capital, LLC | 232,000 | $1,076,000 | 0.23% |
| OXFORD ASSET MANAGEMENT LLP | 968,446 | $4,494,000 | 0.12% |
| FEDERATED HERMES, INC. | 5,641,200 | $26,175,000 | 0.08% |
| HRT FINANCIAL LP | 31,973 | $148,000 | 0.07% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,885,551 | $157,230,000 | 0.04% |